1 Mar 2017 07:00
NMC Health plc to Report Full Year 2016 Results on 8 March 2017
London, 1 March 2017: NMC Health plc (the "Company") will report its full year 2016 financial results (for the twelve months to 31 December 2016) on Wednesday, 8 March 2017.
The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.
Dial-in details for a conference call for analysts and investors will be circulated in due course.
Contacts
NMC
Prasanth Manghat, Deputy Chief Executive Officer | +971 (0)50 522 5648 |
Suresh Krishnamoorthy, Chief Financial Officer | +971 (0)50 591 5365 |
Roy Cherry, Head of Strategy & Investor Relations | +971 (0)50 667 0184 |
Media
FTI Consulting, London
Matthew Cole | +44 (0)20 3727 1101 |
FTI Consulting, Gulf
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
The Group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2 million patients in 2015. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$880.9 million for the year ended 31 December 2015.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.